$item.Name

首页>试剂标物>行业专用试剂>生物试剂

GSK2140944 Gepotidacin

型号
GSK2140944
参数
供货周期:现货 规格:10 mM * 1 mL;1 mg;5 mg 货号:HY-16742 应用领域:生物产业
MedChemExpress LLC

免费会员 

生产厂家

该企业相似产品

Galidesivir hydrochloride

在线询价

Pimodivir

在线询价

莫非赛定 Morphothiadin

在线询价

RRx-001

在线询价

ABX464

在线询价
抑制剂,调节剂,API,天然产物,各种类型化合物库

MedChemExpress (MCE) 专注于为科学家提供高品质的生物活性小分子化合物,化合物库及各类试剂盒,总部位于美国新泽西。
•   MedChemExpress (MCE) 产品作用于 20 多个热门信号通路及研究领域的300多个细分靶点,拥有 10000 特异性抑制剂、激动剂,以及 50 活性化合物筛选库;
•   我们坚持对所有产品进行严格质检,确保产品的高品质和高纯度;
•   MedChemExpress (MCE) 产品已被数万名科学家信赖,并被大量top文献和*引用;
•   我们拥有专业的技术团队追踪前沿科研进展,不断丰富各个靶点的特异性产品,坚持做 “您身边的抑制剂大师”;
•   MedChemExpress (MCE) 与众多药企和科研机构保持深度合作;
•   大量产品有中国库存,工作日 16:00 前订单确保当日发货,次日送达。
MCE 中国站:www.MedChemExpress.cn

Hotline: 400-820-3792
Tel: 021-58955995
Email: sales@MedChemExpress.cn
Tech Support: 021-58950656

MedChemExpress - Inhibitors Agonists

MedChemExpress - Screening Libraries

MedChemExpress - Top Publications Citing Use of MCE

详细信息

Gepotidacin

产品活性:Gepotidacin (GSK2140944)是一种新型的三氮杂苊烯细菌II型拓扑异构酶抑制剂。

研究领域:Anti-infection

作用靶点:Bacterial

In Vitro: Gepotidacin is a novel, first-in-class, triazaacenaphthylene antibacterial that inhibits bacterial DNA gyrase and topoisomerase IV via a unique mechanism and has demonstrated in vitro activity against gram-negative and gram-positive bacterias , including drug-resistant strains, and also targets pathogens associated with other conventional and biothreat infections. The MIC50 and MIC90 for gepotidacin against the 25 N. gonorrhoeae isolates tested are 0.12 and 0.25 μg/mL, respectively. The gepotidacin MIC90s are as follows (in μg/mL): Streptococcus pyogenes, 0.25; Escherichia coli, 2; Moraxella catarrhalis, ≤0.06; Streptococcus pneumoniae, 0.25; Haemophilus influenzae, 1; Clostridium perfringens, 0.5; and Shigella spp., 1. Gepotidacin hasin vitroactivity against causative pathogens of acute bacterial skin and skin structure infections (ABSSSIs).

In Vivo: GSK2140944 MICs are 0.125 to 0.5 mg/L against the six MRSA isolates. ELF penetration ratios range from 1.1 to 1.4. Observed maximal decreases are 1.1 to 3.1 log10 CFU in neutropenic mice. The mean fAUC/MIC ratios required for stasis and 1-log-unit decreases are 59.3 ± 34.6 and 148.4 ± 83.3, respectively.

相关产品:Drug Repurposing Compound Library  |  Anti-Infection Compound Library  |  Clinical Compound Library  |  Clinical Compound Library Plus  |  Drug Repurposing Compound Library Plus  |  Bioactive Compound Library Plus  |  Puromycin Dihydrochloride  |  Tunicamycin  |  G-418 disulfate  |  Hygromycin B  |  Bleomycin sulfate  |  Vancomycin hydrochloride  |  Ampicillin sodium  |  Neomycin sulfate  |  Salinomycin  |  Avibactam sodium  |  Vaborbactam  |  Rifampicin  |  Minocycline hydrochloride  |  Bedaquiline  |  Carbenicillin disodium  |  Ciprofloxacin  |  Gentamicin sulfate  |  Metronidazole  |  Kanamycin sulfate  |  Methicillin sodium salt  |  Eravacycline dihydrochloride  |  Ceftazidime  |  Berberine chloride hydrate  |  Rimonabant Hydrochloride  |  Omadacycline hydrochloride  |  Chloramphenicol  |  Puromycin aminonucleoside  |  Tetracycline hydrochloride  |  Cefotaxime sodium salt

1000+ Inhibitors&Agonists 作用于20多条经典信号通路
30+ Screening Libraries 疾病机制研究的高效工具
CCK8 Kit | Cell Counting Kit-8
FDA-Approved 药物筛选库
Inhibitor Cocktails 蛋白酶, 磷酸酶 & 去乙酰化酶
Top Publications Citing Use of MCE
MCE Hotline: 4008203792 | 中国现货 - 文献引用 - 高纯度高品质 - *技术支持

相关技术文章

同类产品推荐

相关分类导航

产品参数

供货周期 现货
规格 10 mM * 1 mL;1 mg;5 mg
货号 HY-16742
应用领域 生物产业
企业未开通此功能
详询客服 : 0571-87858618
提示

请选择您要拨打的电话:

当前客户在线交流已关闭
请电话联系他 :